Trajan Group Holdings Ltd (trj) Logo

Trajan Group Holdings Ltd (TRJ)

___:___ · AUD
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE

TRJ Chart

TRJ's Principal Activity is the development and manufacture of analytical and life sciences instruments and devices.

Share Price Activity

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2021 YTD
1 Year
vs Sector (1yr) -
vs ASX 200 (1yr) +60.18%

Size

Market Capitalisation
ASX Rank 494 of 2,295
Sector Rank

Key Information

Shares Issued
Sector Healthcare
Similar Companies -
EPS $0.00
DPS $0.00
NTA per share $0.00

Broker Consensus

TRJ is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.

Announcements

Date Heading Pages File Size Time

Company Overview

Trajan Group Holdings Limited (TRJ) is a global developer and manufacturer of analytical science instruments, devices and solutions. Trajan has operations in Australia and across the United States (US), Europe and Asia. Trajan designs and manufactures a portfolio of precision consumable products and devices and solutions.

Incorporation Details

No incorporation details available.

Corporate Details

Head Office Ringwood VIC 3134
Website www.trajanscimed.com
Registry Computershare
Auditor RSM Australia Partners
Date Listed 7 Jun 2021

Upcoming Calendar (Forecasted)

No calendar entries available.

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
No dividends paid.

See Upcoming Dividends for all ASX companies.

Directors & Management

Directors & Management

Name Title Since Bio
Mr Mark Andrew Licciardo Joint Company Secretary Jun 2021
Mr Alister John Hodges Chief Financial Officer,Joint Company Secretary Jun 2021
Mr John Anthony Eales Non-Executive Chairman,Non-Executive Director Mar 2021 Director Bio icon

Mr John Anthony Eales

Non-Executive Chairman,Non-Executive Director

Mr Eales has started a 10 year international sporting career with the Australian rugby team from 1991, captaining the Wallabies from 1996 until 2001. John has served as an executive, adviser, director and investor in a number of listed and unlisted private organizations. John co founded the Mettle Group in 2003 - a corporate consultancy which was acquired by Chandler Macleod in 2007. John currently sits on the ASX boards of Magellan Financial Group and Flight Centre Travel Group. He also sits on the board of FUJIFILM Data Management Solutions Pty Ltd and Executive Health Solutions. He recently stepped down from his role as a Director of The Palladium Group and continues to serve as a consultant to Australian companies, including Westpac. John has been a regular columnist in both the Australian Financial Review and The Australian over the last 20 years and is the author of two books, Learning from Legends Sport and Learning from Legends Business. He is the Chair of the World Rugby Hall of Fame Selection Panel and on the Rugby Australia Bid Advisory Committee for the Rugby World Cup 2027. He is also the member of the Risk Committee of the TRJ.

Ms Sara Elizabeth Watts Non-Executive Director Mar 2021 Director Bio icon

Ms Sara Elizabeth Watts

Non-Executive Director

Ms Watts is an experienced Non Executive Director with financial and operational experience of more than 20 years in a range of industries including technology, education, NFP and resources. Sara's previous executive positions include Chief Financial Officer of IBM Australia/New Zealand, Head of Internal Audit for IBM Asia Pacific and Vice Principal (Operations) at the University of Sydney. Sara is a Non Executive Director of Syrah Resources where she is Chair of the Audit and Risk Committee. Other current appointments include Trustee of the Australian Museum where she is Chair of the Audit and Risk Committee, Non Executive Director of Intrepica (trading as LiteracyPlanet) and Chair of the Audit and Risk Committee of the Independent Broad Based Anti Corruption Commission, Victoria (IBAC). She is also the Chairman of the Risk Committee of the TRJ.

Mr Rohit Khanna Non-Executive Director Mar 2021 Director Bio icon

Mr Rohit Khanna

Non-Executive Director

Mr Khanna has nearly 40 years of experience in analytical science, business leadership and laboratory application software. In 1981, Rohit co founded Dynamic Solutions, a software engineering firm dedicated to providing computing solutions to the scientific and engineering community. The company was acquired by Waters Corporation in 1986. Rohit went on to hold various senior management roles at Waters Corporation, including Vice President and General Manager of the Data Products Group. In 2002, Rohit was appointed Vice President, Worldwide Marketing, and most recently Rohit was Senior Vice President of several Waters Corporation businesses including Informatics, Service, and Chemistry - along with being a member of the Corporate Executive Committee. Rohit retired from Waters Corporation at the end of 2017 but remains connected to the industry, participating on several Boards and providing strategic advisory services. He was also a National Science Foundation Fellow of California Institute of Technology. He is also the member of the Risk Committee of the TRJ.

Ms Tiffiny Jane Lewin Non-Executive Director Mar 2021 Director Bio icon

Ms Tiffiny Jane Lewin

Non-Executive Director

Ms Lewin operational, risk and strategy experience gained over a 30 year career in the consumer goods, manufacturing, professional services and the finance sectors. Tiffiny is currently a senior leader at Westpac Group where she has served since 2015. She is the Director of Root Cause, and previously held roles as General Manager Premium Bank Victoria and Head of Customer Advocate Office. Prior to Westpac, Tiffiny held senior leadership, operational and strategy roles across Australia and Asia for global organizations including Nestle Australia, Nestle Japan, SCA Hygiene, Mondelez International and Procter & Gamble, where she managed organizational transformation, performance turnaround and market growth across business and consumer sectors. Previously, Tiffiny has acted as a board adviser to Trajan. She is also the member of the Risk Committee of the TRJ.

Mr Robert (Bob) John Lyon Head of Corporate Development and General Counsel,Executive Director Sep 2014 Director Bio icon

Mr Robert (Bob) John Lyon

Head of Corporate Development and General Counsel,Executive Director

Mr Lyon has global responsibility for the strategic growth of Trajan's business through mergers and acquisitions, licensing arrangements, and commercial relationships with Trajan's industry, academic, government and research partners in the scientific and medical sectors globally. Prior to joining Trajan, Robert had a 15 year career in law including as a partner at Page Seager Lawyers before spending six years with KPMG Corporate Finance.

Mr Stephen Andrew Tomisich Chief Executive Officer,Co-Founder,Managing Director Aug 2011 Director Bio icon

Mr Stephen Andrew Tomisich

Chief Executive Officer,Co-Founder,Managing Director

Mr Tomisich has entered in the analytical science industry in 1984 and has held several senior leadership roles in the industry, both in Australia and internationally. Immediately prior to co founding Trajan, Stephen was the Chief Executive Officer of SGE Analytical Science, a role he retained until Trajan acquired part of that business in 2013. Other industry roles include Managing Director of PerkinElmer Australia and Africa, Director of Marketing at Vision Systems (since acquired by Danaher), Managing Director of Selby Biolab and other senior roles at Varian Instruments (now Agilent Technologies) in both Australia and the US.

Director Interests

The current holdings of TRJ directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Tiffiny Lewin 23/03/2021 N/A 58,823 88,235 N/A
Rohit Khanna 23/03/2021 117,647 N/A 88,235 N/A
Sara Watts 23/03/2021 N/A N/A 88,235 N/A
John Eales 23/03/2021 N/A 894,117 191,178 N/A
Robert (Bob) Lyon 03/09/2014 N/A 252,940 439,250 N/A
Stephen Tomisich 11/08/2011 N/A 76,470,588 N/A N/A

Shareholder Info

Top 20 Shareholders About the Data

Data supplied by Morningstar and accurate on Jun 3, 2021.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
Tomisich Family Pty Ltd (Tomisich Family A/C) 76,470,588 59.03%
J P Morgan Nominees Australia Pty Limited 14,452,111 11.16%
National Nominees Limited 5,317,321 4.10%
Citicorp Nominees Pty Limited 4,469,120 3.45%
BNP Paribas Nominees Pty Ltd (Agency Lending DRP A/C) 3,132,705 2.42%
CS Third Nominees Pty Limited (HSBC Cust Nom Au Ltd 13 A/C) 3,132,356 2.42%
UBS Nominees Pty Ltd 1,650,861 1.27%
Pershing Australia Nominees Pty Ltd (Accum A/C) 1,343,529 1.04%
Ruck & Maul Pty Ltd (The John Eales Family A/C) 882,353 0.68%
HSBC Custody Nominees (Australia) Limited 705,884 0.54%
Mr Alister John Hodges 588,235 0.45%
Ms Danielle Marie Tomisich 588,235 0.45%
BNP Paribas Noms Pty Ltd (DRP) 437,612 0.34%
HSBC Custody Nominees (Australia) Limited - A/C 2 413,329 0.32%
BNP Paribas Nominees Pty Ltd Hub24 Custodial Serv Ltd (DRP A/C) 383,818 0.30%
Telunapa Pty Ltd (Telunapa Capital A/C) 294,118 0.23%
BNP Paribas Nominees Pty Ltd (IOOF INSMT MGMT LTD DRP) 288,824 0.22%
Zen Ventures Pty Ltd (Zen Ventures A/C) 264,705 0.20%
Netwealth Investments Limited (Wrap Services A/C) 246,937 0.19%
Brispot Nominees Pty Ltd (House Head Nominee A/C) 235,295 0.18%

Shareholder Distribution

As reported in the most recent Annual Report.

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001+ Total
No. of Shareholders 240 301 270 368 37 1,216

Substantial Shareholders

No Substantial Shareholders for TRJ in our database.

Shareholders Buying

12 month transaction history compiled from ASX announcements.

Date Name Bought Previous % New %
07-06-21 Australiansuper Pty Ltd 8,341,177 -- 6.44
07-06-21 Tomisich Family Pty Ltd 76,470,588 -- 59.03

Shareholders Selling

12 month transaction history compiled from ASX announcements.

No sell transactions reported by Substantial Shareholders in the past 12 months.

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
No Financial Year End data available
Page Icon
TRJ Historical Price Data (CSV)
Up to 20 years of EOD share price history
Lock Icon
You must be logged in to access this feature. Please sign up for free or login.
Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.